L-Theanine for GLP-1 Sleep Disruption: The Anxiety-Arousal Pathway

If you have started a GLP-1 receptor agonist — semaglutide, tirzepatide, or another drug in this class — and you are now waking at 2 or 3 in the morning feeling wired and restless rather than simply groggy, you are not alone. This specific pattern of sleep disruption is distinct from the acid reflux that sometimes disturbs sleep early in GLP-1 therapy, and distinct from the delayed sleep onset that melatonin addresses. It has an anxious, hyperaroused quality: the mind is running, the body may feel tense, and returning to sleep feels difficult even though you are genuinely tired. The mechanism behind this pattern is not fully established, but it is plausible that GLP-1 receptor agonists — which act on GLP-1 receptors distributed not only in the pancreas and gut but also in the brain — alter the dopaminergic and reward signaling that governs arousal. GLP-1 receptors are expressed in the hypothalamus, the limbic system, and brainstem regions involved in autonomic regulation. When appetite and reward signaling are disrupted at the level of the central nervous system, arousal thresholds at night may shift, producing a state that resembles mild anxiety-driven wakefulness. L-theanine — an amino acid found naturally in green tea — is one of the few non-sedating anxiolytics with meaningful human clinical trial data. Unlike melatonin, which primarily acts on the circadian/chronobiotic pathway, and unlike magnesium, which exerts NMDA antagonism and smooth muscle relaxation, L-theanine promotes alpha-wave brain activity — the same brainwave pattern associated with alert calm and relaxed focus. Some studies indicate it may also potentiate GABA activity and modulate glutamate signaling, which together may reduce the cortical arousal that underlies the 2–3am wired wakefulness pattern. Critically, L-theanine is typically described as non-sedating: it does not appear to cause the morning grogginess or cognitive blunting associated with sedative sleep aids, benzodiazepines, or antihistamine-based sleep medications. However, individual responses vary — while morning grogginess is less likely to occur with L-theanine than with sedating agents, it cannot be ruled out in all individuals, particularly at higher doses or when combined with other supplements. This page is for adults on GLP-1 receptor agonists who have ruled out or separately addressed reflux-driven wakefulness, who do not have a circadian rhythm delay as their primary complaint, and who are experiencing the specific anxious, wired quality of nighttime arousal. It focuses on the 200mg dose that is most commonly studied and used, explains the mechanism, reviews the three best-value products, and provides the safety context you need before deciding whether L-theanine is appropriate for your situation. As with all supplements discussed on this site, this information is educational and does not constitute medical advice. Please consult your prescribing clinician before adding any supplement to your regimen, particularly if you are on other medications or have underlying health conditions.